West Pharmaceutical [WST] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
West Pharmaceutical
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: West Pharmaceutical wins in 10 metrics, Intuitive Surgical wins in 9 metrics, with 0 ties. West Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | West Pharmaceutical | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.91 | 67.08 | West Pharmaceutical |
| Price-to-Book Ratio | 6.04 | 9.65 | West Pharmaceutical |
| Debt-to-Equity Ratio | 10.52 | 0.00 | Intuitive Surgical |
| PEG Ratio | 1.87 | 2.76 | West Pharmaceutical |
| EV/EBITDA | 22.17 | 52.40 | West Pharmaceutical |
| Profit Margin (TTM) | 16.48% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 20.87% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 20.87% | 30.47% | Intuitive Surgical |
| Return on Equity | 17.72% | 16.04% | West Pharmaceutical |
| Return on Assets (TTM) | 10.53% | 9.02% | West Pharmaceutical |
| Free Cash Flow (TTM) | $276.40M | $1.30B | Intuitive Surgical |
| Dividend Yield | 0.38% | N/A | N/A |
| 1-Year Return | -18.43% | -1.51% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 5.98 | 18.83 | West Pharmaceutical |
| Enterprise Value | $17.50B | $166.94B | Intuitive Surgical |
| EV/Revenue Ratio | 5.91 | 18.26 | West Pharmaceutical |
| Gross Profit Margin (TTM) | 35.73% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $41 | $26 | West Pharmaceutical |
| Earnings per Share (Diluted) | $6.67 | $7.16 | Intuitive Surgical |
| Beta (Stock Volatility) | 1.05 | 1.60 | West Pharmaceutical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
West Pharmaceutical vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| West Pharmaceutical | 1.60% | 2.96% | 17.57% | 13.70% | 21.98% | -24.79% |
| Intuitive Surgical | -0.43% | 0.21% | -7.15% | -14.68% | -21.25% | -8.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| West Pharmaceutical | -18.43% | -18.69% | -9.06% | 334.38% | 1,338.50% | 1,743.21% |
| Intuitive Surgical | -1.51% | 127.01% | 97.74% | 738.64% | 1,479.43% | 5,823.36% |
Performance & Financial Health Analysis: West Pharmaceutical vs Intuitive Surgical
| Metric | WST | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $17.70B | $172.16B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 541,300 | 1,853,870 |
| 90 Day Avg. Volume | 762,767 | 2,048,940 |
| Last Close | $246.99 | $479.20 |
| 52 Week Range | $187.43 - $352.33 | $425.00 - $616.00 |
| % from 52W High | -29.90% | -22.21% |
| All-Time High | $475.35 (Sep 06, 2021) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -48.04% | -22.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.21% |
| Quarterly Earnings Growth | 0.18% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.29% |
| Operating Margin (TTM) | 0.21% | 0.30% |
| Return on Equity (TTM) | 0.18% | 0.16% |
| Debt to Equity (MRQ) | 10.52 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $40.74 | $49.79 |
| Cash per Share (MRQ) | $7.09 | $14.86 |
| Operating Cash Flow (TTM) | $676.70M | $2.83B |
| Levered Free Cash Flow (TTM) | $207.85M | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.38% | N/A |
| Last 12-Month Dividend | $0.83 | N/A |
Valuation & Enterprise Metrics Analysis: West Pharmaceutical vs Intuitive Surgical
| Metric | WST | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.91 | 67.08 |
| Forward P/E | 32.74 | 61.10 |
| PEG Ratio | 1.87 | 2.76 |
| Price to Sales (TTM) | 5.98 | 18.83 |
| Price to Book (MRQ) | 6.04 | 9.65 |
| Market Capitalization | ||
| Market Capitalization | $17.70B | $172.16B |
| Enterprise Value | $17.50B | $166.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.91 | 18.26 |
| Enterprise to EBITDA | 22.17 | 52.40 |
| Risk & Other Metrics | ||
| Beta | 1.05 | 1.60 |
| Book Value per Share (MRQ) | $40.74 | $49.79 |
Financial Statements Comparison: West Pharmaceutical vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | WST | ISRG |
|---|---|---|
| Revenue/Sales | $766.50M | $2.44B |
| Cost of Goods Sold | $492.60M | $822.10M |
| Gross Profit | $273.90M | $1.62B |
| Research & Development | $19.10M | $313.30M |
| Operating Income (EBIT) | $158.90M | $743.40M |
| EBITDA | $203.40M | $898.70M |
| Pre-Tax Income | $157.00M | $832.10M |
| Income Tax | $30.20M | $167.90M |
| Net Income (Profit) | $131.80M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | WST | ISRG |
|---|---|---|
| Cash & Equivalents | $509.70M | $2.57B |
| Total Current Assets | $1.68B | $7.66B |
| Total Current Liabilities | $604.60M | $1.54B |
| Long-Term Debt | $282.40M | N/A |
| Total Shareholders Equity | $2.93B | $17.21B |
| Retained Earnings | $4.14B | $7.14B |
| Property, Plant & Equipment | $3.28B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | WST | ISRG |
|---|---|---|
| Operating Cash Flow | $177.40M | $833.10M |
| Capital Expenditures | N/A | $-116.60M |
| Free Cash Flow | $101.90M | $465.00M |
| Debt Repayment | $-300,000 | N/A |
| Common Stock Repurchase | $-500,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | WST | ISRG |
|---|---|---|
| Shares Short | 2.17M | 4.30M |
| Short Ratio | 2.62 | 2.18 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 541,300 | 1,853,870 |
| Average Daily Volume (90 Day) | 762,767 | 2,048,940 |
| Shares Outstanding | 72.30M | 356.60M |
| Float Shares | 71.39M | 356.33M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.98% | 0.89% |
Dividend Analysis & Yield Comparison: West Pharmaceutical vs Intuitive Surgical
| Metric | WST | ISRG |
|---|---|---|
| Last 12-Month Dividend | $0.83 | N/A |
| Last 12-Month Dividend Yield | 0.38% | N/A |
| 3-Year Avg Annual Dividend | $0.79 | N/A |
| 3-Year Avg Dividend Yield | 0.07% | N/A |
| 3-Year Total Dividends | $2.37 | N/A |
| Ex-Dividend Date | Apr 30, 2025 | N/A |